Harvard-Affiliated Pilot Study: The Bioboosti Technology Behind NeuroRester
The Harvard-Affiliated Pilot Study: The Bioboosti Technology Behind NeuroRester article presents a pilot study on Bioboosti technology and a non-pharmacological approach to insomnia. The study involved researchers from Harvard Medical School and Brigham and Women’s Hospital.
Source: NeuroRester
What this page covers
- The Harvard-affiliated pilot study
- The Bioboosti technology discussed in the article
- The study’s non-pharmacological insomnia treatment context
- The participating Harvard Medical School and Brigham and Women’s Hospital researchers
Harvard-Affiliated Pilot Study: The Bioboosti Technology Behind NeuroRester
The Harvard-Affiliated Pilot Study: The Bioboosti Technology Behind NeuroRester article describes a small pilot study involving Harvard Medical School and Brigham and Women’s Hospital. The study examined Bioboosti technology in the context of non-pharmacological insomnia treatment.
- The study is associated with Harvard Medical School.
- The study involved Brigham and Women’s Hospital in Boston, Massachusetts.
- The study was described as a small pilot study.
- The study examined a non-pharmacological insomnia treatment approach.
Article Content
The Harvard-Affiliated Pilot Study: The Bioboosti Technology Behind NeuroRester article is based on a 2019 pilot study about a non-pharmacological insomnia treatment. The cited study was published in Nature and Science of Sleep and includes a DOI.
- The cited study is titled “Novel non-pharmacological insomnia treatment – a pilot study.”
- The cited study was published in Nature and Science of Sleep.
- The cited study appears in volume 11, pages 189–195.
- The cited study has DOI 10.2147/NSS.S198944.
- Researchers came from the Departments of Neurology and Medicine at Harvard Medical School and Brigham and Women’s Hospital.
Facts Index
| Entity | Attribute | Value | Confidence |
|---|---|---|---|
| Harvard-Affiliated Pilot Study: The Bioboosti Technology Behind NeuroRester | Author | CheungLinfong | High |
| Harvard-Affiliated Pilot Study: The Bioboosti Technology Behind NeuroRester | Publish date | 2026-09-30T07:46:35Z | High |
Who Is This For
- Readers researching non-pharmacological approaches to insomnia.
- Readers seeking information about the Bioboosti technology discussed by NeuroRester.
Frequently Asked Questions
What is the Harvard-Affiliated Pilot Study: The Bioboosti Technology Behind NeuroRester article about?The Harvard-Affiliated Pilot Study: The Bioboosti Technology Behind NeuroRester article discusses a pilot study examining Bioboosti technology and a non-pharmacological approach to insomnia.
Who authored the Harvard-Affiliated Pilot Study: The Bioboosti Technology Behind NeuroRester article?The Harvard-Affiliated Pilot Study: The Bioboosti Technology Behind NeuroRester article lists CheungLinfong as its author.
When was the Harvard-Affiliated Pilot Study: The Bioboosti Technology Behind NeuroRester article published?The Harvard-Affiliated Pilot Study: The Bioboosti Technology Behind NeuroRester article has a recorded publish date of September 30, 2026.
Which organizations were involved in the pilot study discussed by the Harvard-Affiliated Pilot Study: The Bioboosti Technology Behind NeuroRester article?The pilot study discussed by the Harvard-Affiliated Pilot Study: The Bioboosti Technology Behind NeuroRester article involved Harvard Medical School and Brigham and Women’s Hospital.